ITGB6 Human Pre-designed siRNA Set A contains three designed siRNAs for ITGB6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITGB7 Human Pre-designed siRNA Set A contains three designed siRNAs for ITGB7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITGB8 Human Pre-designed siRNA Set A contains three designed siRNAs for ITGB8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITGBL1 Human Pre-designed siRNA Set A contains three designed siRNAs for ITGBL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITIH1 Human Pre-designed siRNA Set A contains three designed siRNAs for ITIH1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITIH2 Human Pre-designed siRNA Set A contains three designed siRNAs for ITIH2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITIH3 Human Pre-designed siRNA Set A contains three designed siRNAs for ITIH3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITIH4 Human Pre-designed siRNA Set A contains three designed siRNAs for ITIH4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITIH5 Human Pre-designed siRNA Set A contains three designed siRNAs for ITIH5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITK Human Pre-designed siRNA Set A contains three designed siRNAs for ITK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Itk Mouse Pre-designed siRNA Set A contains three designed siRNAs for Itk gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Itk Rat Pre-designed siRNA Set A contains three designed siRNAs for Itk gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITLN1 Human Pre-designed siRNA Set A contains three designed siRNAs for ITLN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITM2A Human Pre-designed siRNA Set A contains three designed siRNAs for ITM2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITM2B Human Pre-designed siRNA Set A contains three designed siRNAs for ITM2B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITM2C Human Pre-designed siRNA Set A contains three designed siRNAs for ITM2C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITPA Human Pre-designed siRNA Set A contains three designed siRNAs for ITPA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITPK1 Human Pre-designed siRNA Set A contains three designed siRNAs for ITPK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITPKA Human Pre-designed siRNA Set A contains three designed siRNAs for ITPKA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITPKB Human Pre-designed siRNA Set A contains three designed siRNAs for ITPKB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITPKC Human Pre-designed siRNA Set A contains three designed siRNAs for ITPKC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITPR1 Human Pre-designed siRNA Set A contains three designed siRNAs for ITPR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITPR2 Human Pre-designed siRNA Set A contains three designed siRNAs for ITPR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITPR3 Human Pre-designed siRNA Set A contains three designed siRNAs for ITPR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITPRID2 Human Pre-designed siRNA Set A contains three designed siRNAs for ITPRID2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITPRIP Human Pre-designed siRNA Set A contains three designed siRNAs for ITPRIP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITPRIPL1 Human Pre-designed siRNA Set A contains three designed siRNAs for ITPRIPL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITSN1 Human Pre-designed siRNA Set A contains three designed siRNAs for ITSN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ITSN2 Human Pre-designed siRNA Set A contains three designed siRNAs for ITSN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IVD Human Pre-designed siRNA Set A contains three designed siRNAs for IVD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ivermectin B1a monosaccharide is a modified Ivermectin B1a (HY-126937). Ivermectin B1a monosaccharide is an antiparasite agent with a minimum concentration for full activity in Haemonchus contortus larval development of 0.001 μg/mL[1].

IVL Human Pre-designed siRNA Set A contains three designed siRNAs for IVL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IVNS1ABP Human Pre-designed siRNA Set A contains three designed siRNAs for IVNS1ABP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IWS1 Human Pre-designed siRNA Set A contains three designed siRNAs for IWS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IYD Human Pre-designed siRNA Set A contains three designed siRNAs for IYD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IZUMO1 Human Pre-designed siRNA Set A contains three designed siRNAs for IZUMO1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IZUMO1R Human Pre-designed siRNA Set A contains three designed siRNAs for IZUMO1R gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IZUMO2 Human Pre-designed siRNA Set A contains three designed siRNAs for IZUMO2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IZUMO3 Human Pre-designed siRNA Set A contains three designed siRNAs for IZUMO3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IZUMO4 Human Pre-designed siRNA Set A contains three designed siRNAs for IZUMO4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

J-1149 is a potent ALK5 inhibitor, with an IC50 value of 0.017 μM. J-1149 also shows weak p38α MAP kinase inhibitory activity, with an IC50 value of 0.435 μM. J-1149 can be used for liver fibrosis research[1].

J208 is a dual inhibitor for histone deacetylase (HDAC) and DNA methyltransferase (DNMT). J208 inhibits proliferation of cancer cells, as well as the migration/invasion of TNBC. J208 induces apoptosis, arrests the cell cycle at G0/G1 phase. J2008 activates the innate immune signalling pathway in TNBC, by inducing the expression of endogenous retroviruses (ERVs)[1].

J9Z38 is a metabolite of Cyantraniliprole (HY-12779), a broad-spectrum agrochemical insecticide belonging to the anthranilic diamide insecticide class. Cyantraniliprole effectively controls the growth of various pests on fruits, vegetables, cereals and other crops. Thus, J9Z38 is a key indicator for indirect detection and evaluation of Cyantraniliprole residue levels[1].

Jacaric acid is a conjugated linolenic acid, which inhibits viability in cells PC-3 (IC50 is 11.8 μM), LNCaP (IC50 is 2.2 μM) and DLD-1, induces apoptosis and necrosis[1]. Jacaric acid exhibits anticaner activity against prostate cancer and adenocarcinoma[2]. Jacaric acid exhibits immunomodulating activity in murine peritoneal macrophages as an immunopotentiator[3]. Jacaric acid is orally active.

JADE1 Human Pre-designed siRNA Set A contains three designed siRNAs for JADE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.